ASSESSMENT OF RADIOGRAPHIC PROGRESSION IN PATIENTS WITH SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS TREATED WITH TOCILIZUMAB: 2-YEAR DATA FROM TENDER

被引:0
|
作者
Baildam, Eileen [1 ]
Ravelli, Angelo [2 ]
Malattia, Clara [2 ]
Ruperto, Nicola [2 ]
Palmisani, Elena [2 ]
Pederzoli, Silvia [2 ]
Pistorio, Angela [2 ]
Brunner, Hermine I. [3 ]
Cuttica, Ruben [2 ]
Penades, Inmaculada Calvo [2 ]
Garay, Stella Maris [2 ]
Eleftheriou, Despina [4 ]
Wouters, Carine [2 ]
Wang, Jianmei [5 ]
Devlin, Clare [5 ]
Lovell, Daniel J. [3 ]
Martini, Alberto [2 ]
De Benedetti, Fabrizio [6 ]
机构
[1] Alder Hey Childrens Hosp, Liverpool L12 2AP, Merseyside, England
[2] Paediat Rheumatol Int Trials Org, Genoa, Italy
[3] Pediat Rheumatol Collaborat Study Grp, Cincinnati, OH USA
[4] Great Ormond St Hosp Sick Children, London, England
[5] Roche Prod Ltd, Welwyn Garden City AL7 3AY, Herts, England
[6] IRCCS Osped Pediat Bambino Gesu, Rome, Italy
关键词
D O I
10.1093/rheumatology/keu504
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
PP11
引用
收藏
页码:9 / 9
页数:1
相关论文
共 50 条
  • [31] TAPERING AND WITHDRAWAL OF TOCILIZUMAB IN PATIENTS WITH SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS IN INACTIVE DISEASE: RESULTS FROM AN ALTERNATIVE DOSING REGIMEN IN THE TENDER STUDY
    De Benedetti, F.
    Ruperto, N.
    Brunner, H.
    Grom, A.
    Wulffraat, N.
    Henrickson, M.
    Jerath, R.
    Kimura, Y.
    Kadva, A. K.
    Keane, C.
    Wang, J.
    Wimalasundera, S.
    Gokani, P.
    Martini, A.
    Lovell, D.
    ANNALS OF THE RHEUMATIC DISEASES, 2015, 74 : 835 - 835
  • [32] Tapering and Withdrawal of Tocilizumab in Patients With Systemic Juvenile Idiopathic Arthritis in Inactive Disease: Results From an Alternative Dosing Regimen in the TENDER Study
    De Benedetti, Fabrizio
    Ruperto, Nicolino
    Brunner, Hermine
    Grom, Alexei A.
    Wulffraat, Nico
    Henrickson, Michael
    Jerath, Rita
    Kimura, Yuki
    Kadva, Alysha K.
    Wang, Jianmei
    Martini, Alberto
    Lovell, Daniel J.
    ARTHRITIS & RHEUMATOLOGY, 2014, 66 : S8 - S9
  • [33] Tocilizumab in patients with Systemic Juvenile Idiopathic Arthritis (sJIA): 12-week Pharmacokinetic (PK) and Pharmacodynamic (PD) data from the Phase 3 TENDER Trial
    Ruperto, N.
    Zhang, A.
    Morcos, P. N.
    Huppertz, H.
    Minden, K.
    Myones, B.
    Onel, K.
    Siammopoulou, A.
    Silva, C.
    Kenwright, A.
    Roseti, S.
    De Benedetti, F.
    Lovell, D.
    Martini, A.
    Brunner, H.
    CLINICAL AND EXPERIMENTAL RHEUMATOLOGY, 2011, 29 (02) : 421 - 421
  • [34] TOCILIZUMAB IN PATIENTS WITH SYSTEMIC JUVENILE IDIOPATHIC ARTHRITIS: EFFICACY DATA FROM THE PLACEBO-CONTROLLED 12-WEEK PART OF THE PHASE III TENDER TRIAL
    Chaitow, J.
    De Benedetti, F.
    Brunner, H.
    Ruperto, N.
    Allen, R.
    Murray, K.
    Schneider, R.
    Woo, P.
    Wright, S.
    Kenwright, A.
    Martini, A.
    Lovell, D.
    INTERNAL MEDICINE JOURNAL, 2011, 41 : 32 - 32
  • [35] Efficacy and Safety of Tocilizumab in Patients with Severe Systemic Juvenile Idiopathic Arthritis
    Alekseeva, Ekaterina I.
    Denisova, Rina V.
    Valieva, Saniya I.
    Bsarova, Tatyana M.
    Isaeva, Kseniya B.
    Chistyakova, Evgeniya G.
    Sleptsova, Tatyana V.
    Mitenko, Elena V.
    INTERNATIONAL JOURNAL OF BIOMEDICINE, 2011, 1 (04) : 190 - 198
  • [36] Efficacy, safety and tolerability of tocilizumab in patients with systemic juvenile idiopathic arthritis
    Yokota, Shumpei
    Tanaka, Toshio
    Kishimoto, Tadamitsu
    THERAPEUTIC ADVANCES IN MUSCULOSKELETAL DISEASE, 2012, 4 (06) : 387 - 397
  • [37] EXPERIENCE WITH TOCILIZUMAB IN 29 PATIENTS WITH SYSTEMIC ONSET JUVENILE IDIOPATHIC ARTHRITIS
    Horneff, G.
    Onken, N.
    Hospach, A.
    Ganser, G.
    Huppertz, H. I.
    ANNALS OF THE RHEUMATIC DISEASES, 2013, 72 : 737 - 738
  • [38] SOME PECULARITIES OF THE COURSE OF JUVENILE IDIOPATHIC ARTHRITIS IN PATIENTS TREATED WITH TOCILIZUMAB
    Oshlyanska, O. A.
    Artsymovych, A. G.
    ANNALS OF THE RHEUMATIC DISEASES, 2017, 76 : 1392 - 1392
  • [39] Growth During Tocilizumab Therapy for Polyarticular-course Juvenile Idiopathic Arthritis: 2-year Data from a Phase III Clinical Trial
    Bharucha, Kamal N.
    Brunner, Hermine I.
    Calvo Penades, Inmaculada
    Nikishina, Irina
    Rubio-Perez, Nadina
    Oliveira, Sheila
    Kobusinska, Katarzyna
    Schmeling, Heinrike
    Sztajnbok, Flavio
    Weller-Heinemann, Frank
    Zholobova, Elena
    Zulian, Francesco
    Allen, Roger
    Chaitow, Jeffrey
    Frane, James
    Wells, Chris
    Ruperto, Nicolino
    De Benedetti, Fabrizio
    JOURNAL OF RHEUMATOLOGY, 2018, 45 (08) : 1173 - 1179
  • [40] Short-term outcomes in patients with systemic juvenile idiopathic arthritis treated with either tocilizumab or anakinra
    Kearsley-Fleet, Lianne
    Beresford, Michael W.
    Davies, Rebecca
    De Cock, Diederik
    Baildam, Eileen
    Foster, Helen E.
    Southwood, Taunton R.
    Thomson, Wendy
    Hyrich, Kimme L.
    RHEUMATOLOGY, 2019, 58 (01) : 94 - 102